News

Indu Subaiya, co-founder of Health 2.0 discusses value in bridging the gap between start-ups and European hospital IT leaders.

Pasadena, California-based Embodied announced today it has raised $22 million in Series A funding to support its AI and robotics platforms for improved care and wellness.

The FDA has granted Isreal-based DreaMed Diabetes a de novo request for its artificial intelligence-powered software for providers managing patients with Type 1 diabetes.

In the last few years consumer genomics has grown in both its offerings and legitimacy.

Adrian Zai, MD, offers advice to health systems looking to position themselves for success in the world of accountable care.

Benchling, which offers a software suite for improving collaboration and productivity among life sciences and biotech researchers, has raised $14.

Biometric sensor technology company Valencell announced this week that it has raised $10.

Mindstrong Health, a company that uses phone activity to measure mental health and behavior, has just closed a $15 million Series B funding round.

DyAnsys, a medical device company specializing in the autonomic nervous system, announced this week that it has received FDA approval for a wearable auricular neurostimulation device designed to treat symptoms of opioid withdrawal.

The past month has seen a succession of publications offering support for Click Therapeutics’ digital offering for patients with major depressive disorder (MDD).